type2 diabetes
Conditions
Interventions
Addition of dapagliflozin 5mg
Sponsors
Tokyo Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Outpatients 2) over 20 years old 3) T2DM 4) eGFR over 30 mL/min/1.73 m2 5) Diet and exercise therapies are well performed 6) Patients who are suspected good-compliant 7) Understanding of the study procedures and agreement to participate in the study, by giving written informed consent
Exclusion criteria
Exclusion criteria: 1) Patients suspected of having secondary diabetes (ex. endocrine disease, drug-induced or liver disease) 2) Females who are pregnant or who intend to become pregnant within the study 3) Severe hepatic disease, malignancy, a history of gastrectomy and/or positive for HIV 4) Contraindication with dapagliflozin 5) Patient who disqualified from the study by the investigator for any reason other than given above.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c, glycoalbumin | — |
Secondary
| Measure | Time frame |
|---|---|
| Body weight, Abdominal circumference, blood pressure, liver function, renal function, uric acid, lipid parameters | — |
Countries
Japan
Contacts
Public ContactYasuhiro Iijima
Manda Memorial Hospital Diabetes Center
Outcome results
None listed